Mettler-Toledo International (NYSE:MTD) Now Covered by Wolfe Research

Equities researchers at Wolfe Research began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a report released on Friday. The brokerage set a “peer perform” rating on the medical instruments supplier’s stock.

Other analysts also recently issued reports about the stock. Stifel Nicolaus reduced their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Wells Fargo & Company reduced their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday. Finally, Evercore ISI lifted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,276.98 on Friday. The business’s 50-day simple moving average is $1,305.85 and its 200-day simple moving average is $1,376.86. Mettler-Toledo International has a 52 week low of $1,115.64 and a 52 week high of $1,546.93. The firm has a market capitalization of $26.95 billion, a PE ratio of 34.43, a PEG ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Research analysts forecast that Mettler-Toledo International will post 40.42 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. DGS Capital Management LLC bought a new stake in Mettler-Toledo International during the 3rd quarter worth approximately $237,000. Retirement Systems of Alabama boosted its stake in Mettler-Toledo International by 610.4% in the third quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock worth $50,183,000 after purchasing an additional 28,752 shares in the last quarter. Oddo BHF Asset Management Sas bought a new stake in shares of Mettler-Toledo International during the third quarter worth $1,164,000. Tidal Investments LLC increased its stake in shares of Mettler-Toledo International by 1,073.6% in the third quarter. Tidal Investments LLC now owns 16,407 shares of the medical instruments supplier’s stock valued at $24,606,000 after buying an additional 15,009 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Mettler-Toledo International in the third quarter valued at about $111,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.